Maternal serum markers for fetal trisomy 21 screening

By Muller F.   Bussieres L.  

European Journal of Obstetrics & Gynecology and Reproductive Biology, Vol. 65, Iss. 1, 1996-03 ,pp. : 3-6

Elsevier

Access to resources Recommend Favorite

Screening for trisomy 21 by maternal age, fetal nuchal translucency and maternal serum biochemistry at 11–14 weeks: a German multicenter study

By von Kaisenberg C. S.   Gasiorek-Wiens A.   Bielicki M.   Bahlmann F.   Meyberg H.   Kossakiewicz A.   Pruggmayer M.   Kamin G.   Fritzer E.   Harris C.   Arnold N.  

Journal of Maternal-Fetal and Neonatal Medicine, Vol. 12, Iss. 2, 2002-08 ,pp. : 89-94

Informa Healthcare

Access to resources Recommend Favorite

Prenatal diagnosis of trisomy 20 mosaicism by maternal serum screening for Down syndrome

By Chen J.-H.   Hsu T.-Y.   Ou C.-Y.   Chang L.-F.   Chang S.-Y.   Soong Y.-K.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 86, Iss. 2, 1999-10 ,pp. : 175-177

Elsevier

Access to resources Recommend Favorite

Early first-trimester maternal serum placental growth factor in trisomy 21 pregnancies

By Cowans N. J.   Stamatopoulou A.   Tørring N.   Spencer K.  

Ultrasound in Obstetrics and Gynecology, Vol. 37, Iss. 5, 2011-05 ,pp. : 515-519

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impaired renal function in the mother may result in a high false positive rate in Down Syndrome screening

By Byrd L.   Baker P.  

Journal of Obstetrics & Gynaecology, Vol. 26, Iss. 4, 2006-05 ,pp. : 376-377

Informa Healthcare

Access to resources Recommend Favorite